Membrane partitioning of various δ-opioid receptor forms before and after agonist activations: The effect of cholesterol

Biochimica et Biophysica Acta - Biomembranes

Volumn 1778, Issue 6, 2008, Pages 1483-1492

  André, Aurore ^a   Gaibelet, Gérald ^a   Le Guyader, Laurent ^a   Welby, Michèle ^a   Lopez, André ^a   Lebrun, Chantal ^a  

^a INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

Author keywords

Cholesterol; GPCR; hDOR; Hydrophobic mismatch; Lateral organization; Raft

Indexed keywords

CHOLESTEROL; DELTA OPIATE RECEPTOR; DETERGENT; GREEN FLUORESCENT PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN; HYBRID PROTEIN;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; EMBRYO; HUMAN; HUMAN CELL; LIPID MEMBRANE; LIPID RAFT; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LIPID INTERACTION; PROTEIN STABILITY; RECEPTOR BINDING;

CELL LINE; CHOLESTEROL; DIPRENORPHINE; HUMANS; LIGANDS; MEMBRANE MICRODOMAINS; NARCOTIC ANTAGONISTS; OLIGOPEPTIDES; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, OPIOID, DELTA; RECOMBINANT FUSION PROTEINS; SPHINGOLIPIDS;

EID: 43649092317     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2008.03.017     Document Type: Article

References (57)

1. Edidin M. Lipid microdomains in cell surface membranes. Curr. Opin. Struct. Biol. 7 (1997) 528-532
2. Simons K., and Toomre D. Lipid rafts and signal transduction. Nat. Rev., Mol. Cell. Biol. 1 (2000) 31-39
3. Becher A., and McIlhinney R.A. Consequences of lipid raft association on G-protein-coupled receptor function. Biochem. Soc. Symp. (2005) 151-164
4. Simons K., and Vaz W.L. Model systems, lipid rafts, and cell membranes. Annu. Rev. Biophys. Biomol. Struct. 33 (2004) 269-295
5. Kusumi A., Subczynski W.K., Pasenkiewicz-Gierula M., Hyde J.S., and Merkle H. Spin-label studies on phosphatidylcholine-cholesterol membranes: effects of alkyl chain length and unsaturation in the fluid phase. Biochim. Biophys. Acta 854 (1986) 307-317
6. Almeida P.F., Vaz W.L., and Thompson T.E. Lateral diffusion in the liquid phases of dimyristoylphosphatidylcholine/cholesterol lipid bilayers: a free volume analysis. Biochemistry 31 (1992) 6739-6747
7. Sankaram M.B., and Thompson T.E. Cholesterol-induced fluid-phase immiscibility in membranes. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 8686-8690
8. Xu X., Bittman R., Duportail G., Heissler D., Vilcheze C., and London E. Effect of the structure of natural sterols and sphingolipids on the formation of ordered sphingolipid/sterol domains (rafts). Comparison of cholesterol to plant, fungal, and disease-associated sterols and comparison of sphingomyelin, cerebrosides, and ceramide. J. Biol. Chem. 276 (2001) 33540-33546
9. Munro S. Lipid rafts: elusive or illusive?. Cell 115 (2003) 377-388
10. Edidin M. The state of lipid rafts: from model membranes to cells. Annu. Rev. Biophys. Biomol. Struct. 32 (2003) 257-283
11. Hooper N.M. Detergent-insoluble glycosphingolipid/cholesterol-rich membrane domains, lipid rafts and caveolae. (review). Mol. Membr. Biol. 16 (1999) 145-156
12. Rigaud J.L., Pitard B., and Levy D. Reconstitution of membrane proteins into liposomes: application to energy-transducing membrane proteins. Biochim. Biophys. Acta 1231 (1995) 223-246
13. Schuck S., Honsho M., Ekroos K., Shevchenko A., and Simons K. Resistance of cell membranes to different detergents. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 5795-5800
14. Garner A.E., Smith A., and Hooper N.M. Visualisation of detergent solubilisation of membranes: implications for the isolation of rafts. Biophys. J. 94 (2008) 1326-1340
15. Babiychuk E.B., and Draeger A. Biochemical characterization of detergent-resistant membranes: a systematic approach. Biochem. J. 397 (2006) 407-416
16. Moffett S., Brown D.A., and Linder M.E. Lipid-dependent targeting of G proteins into rafts. J. Biol. Chem. 275 (2000) 2191-2198
17. Chini B., and Parenti M. G-protein coupled receptors in lipid rafts and caveolae: how, when and why do they go there?. J. Mol. Endocrinol. 32 (2004) 325-338
18. Salamon Z., Cowell S., Varga E., Yamamura H.I., Hruby V.J., and Tollin G. Plasmon resonance studies of agonist/antagonist binding to the human delta-opioid receptor: new structural insights into receptor-ligand interactions. Biophys. J. 79 (2000) 2463-2474
19. Alves I.D., Cowell S.M., Salamon Z., Devanathan S., Tollin G., and Hruby V.J. Different structural states of the proteolipid membrane are produced by ligand binding to the human delta-opioid receptor as shown by plasmon-waveguide resonance spectroscopy. Mol. Pharmacol. 65 (2004) 1248-1257
20. Alves I.D., Salamon Z., Hruby V.J., and Tollin G. Ligand modulation of lateral segregation of a G-protein-coupled receptor into lipid microdomains in sphingomyelin/phosphatidylcholine solid-supported bilayers. Biochemistry 44 (2005) 9168-9178
21. Kalipatnapu S., and Chattopadhyay A. Membrane organization of the human serotonin(1A) receptor monitored by detergent insolubility using GFP fluorescence. Mol. Membr. Biol. 22 (2005) 539-547
22. Saulière A., Gaibelet G., Millot C., Mazères S., Lopez A., and Salomé L. Diffusion of the mu opioid receptor at the surface of human neuroblastoma SH-SY5Y cells is restricted to permeable domains. FEBS. Lett. 580 (2006) 5227-5231
23. Cheng Y., and Prusoff W.H. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem. Pharmacol. 22 (1973) 3099-3108
24. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. J. Biol.Chem. 193 (1951) 265-275
25. Bligh E.G., and Dyer W.J. A rapid method of total lipid extraction and purification. Can. J. Med. Sci. 37 (1959) 911-917
26. Zak B., Dickenman R.C., White E.G., Burnett H., and Cherney P.J. Rapid estimation of free and total cholesterol. Am. J. Clin. Pathol. 24 (1954) 1307-1315
27. Rouser G., Fkeischer S., and Yamamoto A. Two dimensional then layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots. Lipids 5 (1970) 494-496
28. H. Bullova, P. Balgavy, Turbidimetric study of unilamellar extruded egg phosphatidylcholine liposomes, Acta Facultatis Pharmaceuticae Universitatis Comenianae Tomus II (2005).
29. Lakowicz J.R. Principles of fluorescence spectroscopy (1999), Plenum Press, New-York
30. Mazères S., Schram V., Tocanne J.F., and Lopez A. 7-nitrobenz-2-oxa-1,3-diazole-4-yl-labeled phospholipids in lipid membranes: differences in fluorescence behavior. Biophys. J. 71 (1996) 327-335
31. Patterson G., Day R.N., and Piston D. Fluorescent protein spectra. J. Cell. Sci. 114 (2001) 837-838
32. Riddick J.A., and Bunger W.B. Organic Solvents. Physical Properties and Methods of Purification (1970), John Wiley and Sons, New-York
33. Mosberg H.I., Hurst R., Hruby V.J., Gee K., Yamamura H.I., Galligan J.J., and Burks T.F. Bis-penicillamine enkephalins possess highly improved specificity toward delta opioid receptors. Proc. Natl. Acad. Sci. U. S. A. 80 (1983) 5871-5874
34. Misicka A., Lipkowski A.W., Fang L., Knapp R.J., Davis P., Kramer T., Burks T.F., Yamamura H.I., Carr D.B., and Hruby V.J. Topographical requirements for delta opioid ligands: presence of a carboxyl group in position 4 is not critical for deltorphin high delta receptor affinity and analgesic activity. Biochem. Biophys. Res. Commun. 180 (1991) 1290-1297
35. Sot J., Bagatolli L.A., Goni F.M., and Alonso A. Detergent-resistant, ceramide-enriched domains in sphingomyelin/ceramide bilayers. Biophys. J. 90 (2006) 903-914
36. Giocondi M.C., Seantier B., Dosset P., Milhiet P.E., and Le Grimellec C. Characterizing the interactions between GPI-anchored alkaline phosphatases and membrane domains by AFM. Pflugers. Arch. 456 (2008) 179-188
37. Gaus K., Rodriguez M., Ruberu K.R., Gelissen I., Sloane T.M., Kritharides L., and Jessup W. Domain-specific lipid distribution in macrophage plasma membranes. J. Lipid Res. 46 (2005) 1526-1538
38. Pike L.J., Han X., Chung K.N., and Gross R.W. Lipid rafts are enriched in arachidonic acid and plasmenylethanolamine and their composition is independent of caveolin-1 expression: a quantitative electrospray ionization/mass spectrometric analysis. Biochemistry 41 (2002) 2075-2088
39. Drevot P., Langlet C., Guo X.J., Bernard A.M., Colard O., Chauvin J.P., Lasserre R., and He H.T. TCR signal initiation machinery is pre-assembled and activated in a subset of membrane rafts. EMBO J. 21 (2002) 1899-1908
40. Drobnik W., Borsukova H., Bottcher A., Pfeiffer A., Liebisch G., Schutz G.J., Schindler H., and Schmitz G. Apo AI/ABCA1-dependent and HDL3-mediated lipid efflux from compositionally distinct cholesterol-based microdomains. Traffic 3 (2002) 268-278
41. Röper K., Corbei D., and Huttner W.B. Retention of prominin in microvilli reveals distinct cholesterol-based lipid micro-domains in the apical plasma membrane. Nat. Cell Biol. 2 (2000) 582-592
42. Lenne P.F., Wawrezinieck L., Conchonaud F., Wurtz O., Boned A., Guo X.J., Rigneault H., He H.T., and Marguet D. Dynamic molecular confinement in the plasma membrane by microdomains and the cytoskeleton meshwork. EMBO J. 25 (2006) 3245-3256
43. Macdonald J.L., and Pike L.J. A simplified method for the preparation of detergent-free lipid rafts. J. Lipid Res. 46 (2005) 1061-1067
44. Pike L.J. Lipid rafts: heterogeneity on the high seas. Biochem. J. 378 (2004) 281-292
45. Samama P., Cotecchia S., Costa T., and Lefkowitz R.J. A mutation-induced activated state of the beta 2-adrenergic receptor. Extending the ternary complex model. J. Biol. Chem. 268 (1993) 4625-4636
46. Huang P., Xu W., Yoon S.I., Chen C., Chong P.L., and Liu-Chen L.Y. Cholesterol reduction by methyl-beta-cyclodextrin attenuates the delta opioid receptor-mediated signaling in neuronal cells but enhances it in non-neuronal cells. Biochem. Pharmacol. 73 (2007) 534-549
47. Galbiati F., Razani B., and Lisanti M.P. Emerging themes in lipid rafts and caveolae. Cell 106 (2001) 403-411
48. Eckert G.P., Igbavboa U., Muller W.E., and Wood W.G. Lipid rafts of purified mouse brain synaptosomes prepared with or without detergent reveal different lipid and protein domains. Brain Res. 962 (2003) 144-150
49. Oh P., and Schnitzer J.E. Segregation of heterotrimeric G proteins in cell surface microdomains. G(q) binds caveolin to concentrate in caveolae, whereas G(i) and G(s) target lipid rafts by default. Mol. Biol. Cell 12 (2001) 685-698
50. Schnitzer J.E., McIntosh D.P., Dvorak A.M., Liu J., and Oh P. Separation of caveolae from associated microdomains of GPI-anchored proteins. Science 269 (1995) 1435-1439
51. Albert A.D., Young J.E., and Yeagle P.L. Rhodopsin-cholesterol interactions in bovine rod outer segment disk membranes. Biochim. Biophys. Acta 1285 (1996) 47-55
52. Lagane B., Gaibelet G., Meilhoc E., Masson J.M., Cézanne L., and Lopez A. Role of sterols in modulating the human mu-opioid receptor function in Saccharomyces cerevisiae. J. Biol. Chem. 275 (2000) 33197-33200
53. Pucadyil T.J., and Chattopadhyay A. Role of cholesterol in the function and organization of G-protein coupled receptors. Prog. Lipid Res. 45 (2006) 295-333
54. Perez D.M., Hwa J., Gaivin R., Mathur M., Brown F., and Graham R.M. Constitutive activation of a single effector pathway: evidence for multiple activation states of a G protein-coupled receptor. Mol. Pharmacol. 49 (1996) 112-122
55. Kenakin T. Agonist-receptor efficacy. II. Agonist trafficking of receptor signals. Trends Pharmacol. Sci. 16 (1995) 232-238
56. Burger K., Gimpl G., and Fahrenholz F. Regulation of receptor function by cholesterol. Cell. Mol. Life Sci. 57 (2000) 1577-1592
57. Abe F., and Iida H. Pressure-induced differential regulation of the two tryptophan permeases Tat1 and Tat2 by ubiquitin ligase Rsp5 and its binding proteins, Bul1 and Bul2. Mol. Cell. Biol. 23 (2003) 7566-7584